News

The funding was led by MC Silicon Valley/Mitsubishi International and joined by existing investors including Montreux Equity Partners, Thomas Fogarty, and CN Investment Partners. In connection with the

The lawsuit is in response to the submission of an abbreviated new drug application to the FDA by Sandoz requesting approval to manufacture and sell generic versions of

With this instrument launch Miltenyi Biotec broadens the product portfolio of the cell analysis business section and offers customers a milestone flow cytometer with novel features. According to

Under the terms of the agreement, Circ Pharma will fund the development of the product and IntelGenx will receive royalties from the product’s sales. IntelGenx will use its

It is believed that a majority of the layoffs will include sales representatives and middle managers who comprise one-third of Pfizer’s marketing workforce. Pfizer may also extend its

According to the company, the system was introduced into the Japanese industrial market with a high acceptance due to the improved productivity of their processes and significant savings

In relation to the acquisition of Ranbaxy shares announced in June 2008, and in accordance with the legal requirements in India, Daiichi Sankyo is scheduled to implement an

Edunn’s lead drug candidate, EDN-OL1, is an oligonucleotide-based drug that has shown promise in halting and reversing the progression of Alzheimer’s disease (AD) in animal models. EDN-OLI reduces

In a recent study, ConsumerLab.com evaluated coenzyme Q10 (CoQ10) and ubiquinol products from various nutritional supplement manufacturers to determine whether they contained the amounts of the compounds as